BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7234061)

  • 1. [Determination of the activated recalcification time (ART) in citrated blood].
    Lutze G; Urbahn H
    Z Med Lab Diagn; 1981; 22(1):37-42. PubMed ID: 7234061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clotting time and kaolin clotting time].
    Amagai H; Murakami M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():581-3. PubMed ID: 15658394
    [No Abstract]   [Full Text] [Related]  

  • 3. [Partial thromboplastin time activated with kaolin (PTTTK), a sensitive test of total plasmatic coagulability].
    Poppa C; Enache F; Cernat M
    Stud Cercet Med Interna; 1972; 13(5):489-93. PubMed ID: 4645066
    [No Abstract]   [Full Text] [Related]  

  • 4. [The kaolin-activated recalcification test in the screening of coagulation disorders and in the control of anticoagulant therapy].
    Barberi G; Fiocca S
    Quad Sclavo Diagn; 1977 Jun; 13(2):167-75. PubMed ID: 594303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
    Korsan-Bengtsen K
    Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory management of the bleeding patient.
    Taylor LJ
    Clin Lab Sci; 2003; 16(2):111-4. PubMed ID: 12757191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of activated recalcification time in thrombocyte-poor plasma].
    Kuhfahl E
    Z Med Lab Diagn; 1986; 27(8):451-7. PubMed ID: 3564626
    [No Abstract]   [Full Text] [Related]  

  • 8. A method for testing APC resistance in thrombophilic patients.
    Sochynsky CL; Joyner A; Ortel TI
    Am Clin Lab; 1994 Jul; 13(7):26-7. PubMed ID: 10147384
    [No Abstract]   [Full Text] [Related]  

  • 9. The kaolin partial thromboplastin time as a screening test for coagulation disorders.
    Lurie A; Smith S
    S Afr Med J; 1968 May; 42(18):438-44. PubMed ID: 5655371
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation tests ].
    Fukue H; Fukutake K
    Rinsho Byori; 1997 Nov; Suppl():99-106. PubMed ID: 9508613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the activated blood recalcification time].
    Knopf HJ; Tappert C
    Z Med Lab Diagn; 1984; 25(4):239-40. PubMed ID: 6475204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative basis of a method for the recalcification of citrated blood in researching blood coagulation].
    Sukhanov VA; Koriakov IO
    Lab Delo; 1985; (12):722-4. PubMed ID: 2418267
    [No Abstract]   [Full Text] [Related]  

  • 13. Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants.
    Edson JR; Krivit W; White JG
    J Lab Clin Med; 1967 Sep; 70(3):463-70. PubMed ID: 6072020
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of the partial thromboplastin time in the detection of blood coagulation disorders.
    Whetham J
    Can J Med Technol; 1966 Jun; 28(3):81-96. PubMed ID: 5937814
    [No Abstract]   [Full Text] [Related]  

  • 15. [A sensitive method of diagnosing hypercoagulation of the blood].
    Sukhanov VA; Koriakov IO; Amon EP
    Lab Delo; 1991; (7):27-31. PubMed ID: 1724031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 17. The activated plasma recalcification time. A Measurement encompassing the activated partial thromboplastin time and platelet function, with improved detection of bleeders.
    Vura RC; Speicher CE
    Am J Clin Pathol; 1975 Jul; 64(1):80-6. PubMed ID: 1155378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of oxidative stress as a component of critical states in the genesis of hemostatic disorders].
    Pasechnik IN; Azizov IuM; Nikushkin EV; Barinov VG; Larionov AS
    Anesteziol Reanimatol; 2001; (3):41-3. PubMed ID: 11510357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The partial thromboplastin test in the preoperative "screening" of hemorrhagic patients].
    Bracali G; Niccoli Vallesi R; Rubertelli M
    Ann Laringol Otol Rinol Faringol; 1967; 66(3):333-7. PubMed ID: 5632636
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemostasis: Part I. Screening tests to evaluate abnormal hemostasis.
    Longberry J
    Am J Med Technol; 1982 Feb; 48(2):99-105. PubMed ID: 7064992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.